Clinical characteristics, seizure control, and delivery outcomes in pregnant women with focal and generalized epilepsies
- PMID: 38335875
- DOI: 10.1016/j.seizure.2024.01.017
Clinical characteristics, seizure control, and delivery outcomes in pregnant women with focal and generalized epilepsies
Abstract
Objective: To prospectively investigate the course of epilepsy and assess seizure control during pregnancy in women with focal epilepsy (FE) compared with generalized epilepsy (GE), to ascertain the effects of epilepsy and its types on delivery and neonatal outcomes, and to compare adverse outcomes between pregnancies complicated by epilepsy and normal pregnancies.
Methods: 124 pregnant women with epilepsy (WWE) were enrolled in a prospective study. Obstetric and neonatal outcomes were compared with those of 277 healthy women in the control group.
Results: Occurrence of seizures during pregnancy was more often in FE (77.1 %) compared with GE (50.0 %) (Odds ratio [OR] 2.08; 95 % confidence interval [CI] 0.97-4.46, p = 0.06); the overall seizure freedom was significantly higher in women with GE compared with women with FE (p = 0.0038). Poor seizure control one year prior to the pregnancy and nonadherence to treatment were significantly associated with presence of seizures during pregnancy (p < 0.0001). Compared with pregnancies of women without epilepsy, WWE were at increased risk of cesarean section (CS) (p < 0.0001) and preterm birth (p = 0.03). Offspring of mothers with epilepsy were at higher risks of Apgar scores at 5 min ≤7 (p < 0.0001) and perinatal hypoxia (p = 0.03) compared with infants of unaffected women. Seizures during pregnancy were significantly correlated with the higher rate of CS, Apgar scores at 5 min ≤7, and perinatal hypoxia (p = 0.0069; p = 0.0098; and p = 0.0045, respectively). The risks of adverse outcomes were not significantly increased in women with FE compared to women with GE.
Conclusion: Epileptic seizures in pregnancy are associated with increased risks of adverse delivery and neonatal outcomes. Hence, early assessment of seizure disorder, adequate seizure control prior to and during pregnancy, and effective treatment are required to prevent potential seizure-related complications and improve maternal and fetal outcomes.
Keywords: Delivery and neonatal outcomes; Epilepsy; Pregnant women with epilepsy; Seizure.
Copyright © 2024 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have seemed to influence the work reported in this paper.
Similar articles
-
Clinical characteristics and outcomes in pregnant women with epilepsy.Epilepsy Behav. 2020 Nov;112:107433. doi: 10.1016/j.yebeh.2020.107433. Epub 2020 Sep 9. Epilepsy Behav. 2020. PMID: 32919204
-
The impact of maternal epilepsy on delivery and neonatal outcomes.Childs Nerv Syst. 2020 Apr;36(4):775-782. doi: 10.1007/s00381-019-04435-2. Epub 2019 Nov 30. Childs Nerv Syst. 2020. PMID: 31786631
-
Maternal and fetal outcomes of antiepileptic treatments during pregnancy: A retrospective study.Epilepsy Behav. 2024 Sep;158:109937. doi: 10.1016/j.yebeh.2024.109937. Epub 2024 Jul 13. Epilepsy Behav. 2024. PMID: 39002279
-
Contraception, pregnancy and lactation in women with epilepsy.Baillieres Clin Neurol. 1996 Dec;5(4):887-908. Baillieres Clin Neurol. 1996. PMID: 9068887 Review.
-
Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.Cochrane Database Syst Rev. 2019 Jun 24;6(6):CD012065. doi: 10.1002/14651858.CD012065.pub3. Cochrane Database Syst Rev. 2019. PMID: 31233229 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical